Surgery Partners, Inc.
SGRY
$12.36
-$0.29-2.29%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 3.31B | 3.29B | 3.24B | 3.17B | 3.11B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.31B | 3.29B | 3.24B | 3.17B | 3.11B |
| Cost of Revenue | 2.54B | 2.50B | 2.47B | 2.42B | 2.37B |
| Gross Profit | 765.00M | 786.40M | 768.60M | 752.20M | 745.60M |
| SG&A Expenses | 118.20M | 130.50M | 137.30M | 141.50M | 138.70M |
| Depreciation & Amortization | 176.00M | 150.00M | 160.70M | 155.20M | 152.60M |
| Other Operating Expenses | -8.70M | -13.10M | -13.60M | -18.00M | -20.00M |
| Total Operating Expenses | 2.83B | 2.77B | 2.75B | 2.70B | 2.64B |
| Operating Income | 479.50M | 519.00M | 484.20M | 473.50M | 474.30M |
| Income Before Tax | 116.90M | 148.50M | 128.60M | 118.10M | 147.10M |
| Income Tax Expenses | 18.00M | 125.20M | 124.20M | 130.20M | 134.60M |
| Earnings from Continuing Operations | 98.90 | 23.30 | 4.40 | -12.10 | 12.50 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -176.80M | -194.70M | -184.80M | -181.30M | -180.60M |
| Net Income | -77.90M | -171.40M | -180.40M | -193.40M | -168.10M |
| EBIT | 479.50M | 519.00M | 484.20M | 473.50M | 474.30M |
| EBITDA | 655.50M | 669.00M | 644.90M | 628.70M | 626.90M |
| EPS Basic | -0.61 | -1.36 | -1.43 | -1.53 | -1.33 |
| Normalized Basic EPS | -0.26 | -0.13 | -0.10 | -0.05 | 0.02 |
| EPS Diluted | -0.62 | -1.36 | -1.43 | -1.53 | -1.33 |
| Normalized Diluted EPS | -0.26 | -0.13 | -0.10 | -0.05 | 0.02 |
| Average Basic Shares Outstanding | 508.82M | 507.00M | 505.96M | 505.12M | 504.49M |
| Average Diluted Shares Outstanding | 508.82M | 507.00M | 505.96M | 505.12M | 504.49M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |